Self-Synthesizing Nanorods from Dynamic Combinatorial Libraries against Drug Resistant Cancer

Angew Chem Int Ed Engl. 2021 Feb 8;60(6):3062-3070. doi: 10.1002/anie.202010937. Epub 2020 Dec 16.

Abstract

Molecular self-assembly has been widely used to develop nanocarriers for drug delivery. However, most of them have unsatisfactory drug loading capacity (DLC) and the dilemma between stimuli-responsiveness and stability, stagnating their translational process. Herein, we overcame these drawbacks using dynamic combinatorial chemistry. A carrier molecule was spontaneously and quantitatively synthesized, aided by co-self-assembly with a template molecule and an anti-cancer drug doxorubicin (DOX) from a dynamic combinatorial library that was operated by disulfide exchange under thermodynamic control. The highly selective synthesis guaranteed a stable yet pH- and redox- responsive nanocarrier with a maximized DLC of 40.1 % and an enhanced drug potency to fight DOX resistance in vitro and in vivo. Our findings suggested that harnessing the interplay between synthesis and self-assembly in complex chemical systems could yield functional nanomaterials for advanced applications.

Keywords: cancer drug resistance; drug delivery; dynamic combinatorial chemistry; self-assembly; systems chemistry.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents / chemistry*
  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • Doxorubicin / chemistry*
  • Doxorubicin / pharmacology
  • Doxorubicin / therapeutic use
  • Drug Carriers / chemistry*
  • Drug Resistance, Neoplasm / drug effects
  • Humans
  • Hydrogen-Ion Concentration
  • Mice
  • Mice, Nude
  • Nanotubes / chemistry*
  • Neoplasms / drug therapy
  • Neoplasms / pathology
  • Oxidation-Reduction
  • Transplantation, Heterologous

Substances

  • Antineoplastic Agents
  • Drug Carriers
  • Doxorubicin